業績下滑宣佈回購 藍思科技(300433.SZ)底部拉昇漲近8%
格隆匯10月26日丨昨晚公佈業績的藍思科技(300433.SZ)盤初一度跌超4%至階段新低價18.37元(2020年6月以來新低),在10:30後出現明顯拉昇走勢,截至半日收盤漲7.97%報20.87元,市值1038億元。公司昨晚發佈財報顯示,第三季度營收125.35億元,同比增19.21%;淨利潤9.89億元,同比下降34.97%;前三季度營收339.26億元,同比增30.07%;淨利潤32.97億元,同比下降3.94%。同時,公司發佈了股份回購公吿,擬使用自有資金以集中競價交易方式回購公司A股股份,用於實施員工持股計劃或股權激勵計劃,回購金額3億元至5億元,擬回購的股份價格不超過30元/股。


Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.